BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28348567)

  • 1. Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies.
    Carrega P; Ferlazzo G
    Front Immunol; 2017; 8():277. PubMed ID: 28348567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
    Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
    Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient's Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers.
    Messaoudene M; Frazao A; Gavlovsky PJ; Toubert A; Dulphy N; Caignard A
    Front Immunol; 2017; 8():683. PubMed ID: 28659921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Distinct Natural Killer Cell Subsets in Anticancer Response.
    Stabile H; Fionda C; Gismondi A; Santoni A
    Front Immunol; 2017; 8():293. PubMed ID: 28360915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.
    Pasero C; Gravis G; Guerin M; Granjeaud S; Thomassin-Piana J; Rocchi P; Paciencia-Gros M; Poizat F; Bentobji M; Azario-Cheillan F; Walz J; Salem N; Brunelle S; Moretta A; Olive D
    Cancer Res; 2016 Apr; 76(8):2153-65. PubMed ID: 27197252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.
    Battella S; Cox MC; Santoni A; Palmieri G
    J Leukoc Biol; 2016 Jan; 99(1):87-96. PubMed ID: 26136506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.
    Gras Navarro A; Björklund AT; Chekenya M
    Front Immunol; 2015; 6():202. PubMed ID: 25972872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.
    Dahlberg CI; Sarhan D; Chrobok M; Duru AD; Alici E
    Front Immunol; 2015; 6():605. PubMed ID: 26648934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of macrophages and the tumor microenvironment on natural killer cells.
    Krneta T; Gillgrass A; Ashkar AA
    Curr Mol Med; 2013 Jan; 13(1):68-79. PubMed ID: 22834841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Natural Killer Cell Function by STAT3.
    Cacalano NA
    Front Immunol; 2016; 7():128. PubMed ID: 27148255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK Cells and Cancer Immunoediting.
    Guillerey C; Smyth MJ
    Curr Top Microbiol Immunol; 2016; 395():115-45. PubMed ID: 26025472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine regulation of natural killer cell effector functions.
    Zwirner NW; Domaica CI
    Biofactors; 2010; 36(4):274-88. PubMed ID: 20623510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects.
    Bassani B; Baci D; Gallazzi M; Poggi A; Bruno A; Mortara L
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30939820
    [No Abstract]   [Full Text] [Related]  

  • 14. Human NK cells and NK receptors.
    Bellora F; Castriconi R; Dondero A; Carrega P; Mantovani A; Ferlazzo G; Moretta A; Bottino C
    Immunol Lett; 2014 Oct; 161(2):168-73. PubMed ID: 24361820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tumor cells and tumor microenvironment on NK-cell function.
    Vitale M; Cantoni C; Pietra G; Mingari MC; Moretta L
    Eur J Immunol; 2014 Jun; 44(6):1582-92. PubMed ID: 24777896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress.
    Hasmim M; Messai Y; Ziani L; Thiery J; Bouhris JH; Noman MZ; Chouaib S
    Front Immunol; 2015; 6():482. PubMed ID: 26441986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics.
    Coyle KM; Hawke LG; Ormiston ML
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advance on adaptive immune therapy with natural killer cells--review].
    Chen GH; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):798-802. PubMed ID: 20561454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.